Abstract:Background: In vitro studies often use two-dimensional (2D) monolayers, but 3D cell organization, such as in spheroids, better mimics the complexity of solid tumors. To metastasize, cancer cells undergo the process of epithelial-to-mesenchymal transition (EMT) to become more invasive and pro-angiogenic, with expression of both epithelial and mesenchymal markers. Aims: We asked whether EMMPRIN/CD147 contributes to the formation of the 3D spheroid structure, and whether spheroids, which are often used to study proliferation and drug resistance, could better model the EMT process and the metastatic properties of cells, and improve our understanding of the role of EMMPRIN in them. Methods: We used the parental mouse CT26 colon carcinoma (CT26-WT) cells, and infected them with a lentivirus vector to knock down EMMPRIN expression (CT26-KD cells), or with an empty lentivirus vector (CT26-NC) that served as a negative control. In some cases, we repeated the experiments with the 4T1 or LLC cell lines. We compared the magnitude of change between CT26-KD and CT26-WT/NC cells in different metastatic properties in cells seeded as monolayers or as spheroids formed by the scaffold-free liquid overlay method. Results: We show that reduced EMMPRIN expression changed the morphology of cells and their spatial organization in both 2D and 3D models. The 3D models more clearly demonstrated how reduced EMMPRIN expression inhibited proliferation and the angiogenic potential, while it enhanced drug resistance, invasiveness, and EMT status, and moreover it enhanced cell dormancy and prevented CT26-KD cells from forming metastatic-like lesions when seeded on basement membrane extract (BME). Most interestingly, this approach enabled us to identify that EMMPRIN and miR-146a-5p form a negative feedback loop, thus identifying a key mechanism for EMMPRIN activities. These results underline EMMPRIN role as a gatekeeper that prevents dormancy, and suggest that EMMPRIN links EMT characteristics to the process of spheroid formation. Conclusions: Thus, 3D models can help identify mechanisms by which EMMPRIN facilitates tumor and metastasis progression, which might render EMMPRIN as a promising target for anti-metastatic tumor therapy.

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

Activation of the Planar Cell Polarity Formin Daam1 Leads to Inhibition of Endothelial Cell Proliferation, Migration, and Angiogenesis

Apelin-13 Promotes Late Endothelial Progenitor Cells Differentiation by Regulating Krüppel-like Factor 4.

ERK1/2 Pathway-Mediated Norepinephrine Regulates Function of Endothelial Progenitor Cells

Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood–Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway

Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells

Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood–Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway

Role of Camp-Dependent Protein Kinase A Activity in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood–Tumor Barrier

Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier

SHP2 Protects Endothelial Cell Barrier Through Suppressing VE-cadherin Internalization Regulated by MET-ARF1

Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1.

Endomucin selectively regulates vascular endothelial growth factor receptor-2 endocytosis through its interaction with AP2

CEMIP regulates the proliferation and migration of vascular smooth muscle cells in atherosclerosis through the WNT-beta-catenin signaling pathway.

Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling.

Ephrin-B2/Fc Promotes Proliferation and Migration, and Suppresses Apoptosis in Human Umbilical Vein Endothelial Cells.

Endomucin regulates the endothelial cytoskeleton independent of VEGF

Low-dose Endothelial Monocyte-Activating Polypeptide-Ii Increases Permeability of Blood–tumor Barrier Via a PKC-ζ/PP2A-dependent Signaling Mechanism

AMPK-KLF2 Signaling Pathway Mediates the Proangiogenic Effect of Erythropoietin in Endothelial Colony-Forming Cells.

Hypoxia Induces the Proliferation of Endothelial Progenitor Cells Via Upregulation of Apelin/APLNR/MAPK Signaling.

Endothelial-monocyte-activating Polypeptide II Increases Blood–tumor Barrier Permeability by Down-Regulating the Expression Levels of Tight Junction Associated Proteins

EMMPRIN promotes spheroid organization and metastatic formation: comparison between monolayers and spheroids of CT26 colon carcinoma cells